{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:14:37Z","timestamp":1790874877007,"version":"4.1.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To explore the effective components and mechanism of Polygonati Rhizoma (PR) in the treatment of osteoporosis (OP) based on network pharmacology and molecular docking methods.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The effective components and predicted targets of PR were obtained through the Traditional Chinese Medicine Systems Pharmacology and Analysis Platform (TCMSP) database. The disease database was used to screen the disease targets of OP. The obtained key targets were uploaded to the Search Tool for the Retrieval of Interacting Genes\/Proteins (STRING) database for protein-protein interaction (PPI) network analysis. The Database for Annotation, Visualization, and Integrated Discovery (DAVID) was used for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses of key targets. Analysis and docking verification of chemical effective drug components and key targets were performed with IGEMDOCK software.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 12 chemically active components, 84 drug target proteins and 84 common targets related to drugs and OP were obtained. Key targets such as JUN, TP53, AKT1, ESR1, MAPK14, AR and CASP3 were identified through PPI network analysis. The results of enrichment analysis showed that the potential core drug components regulate the HIF-1 signaling pathway, PI3K-Akt signaling pathway, estrogen signaling pathway and other pathways by intervening in biological processes such as cell proliferation and apoptosis and estrogen response regulation, with an anti-OP pharmacological role. The results of molecular docking showed that the key targets in the regulatory network have high binding activity to related active components.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>PR may regulate OP by regulating core target genes, such as JUN, TP53, AKT1, ESR1, AR and CASP3, and acting on multiple key pathways, such as the HIF-1 signaling pathway, PI3K-Akt signaling pathway, and estrogen signaling pathway.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2021.815891","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T06:28:27Z","timestamp":1641364107000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":39,"title":["Exploration of the Molecular Mechanism of Polygonati Rhizoma in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking"],"prefix":"10.3389","volume":"12","author":[{"given":"Jinlong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangzheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanjun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianke","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115833","article-title":"The Treatment Gap: The Missed Opportunities for Osteoporosis Therapy","volume":"144","author":"Fuggle","year":"2021","journal-title":"Bone"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2269","article-title":"The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine","volume":"29","author":"Wright","year":"2014","journal-title":"J Bone Miner Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207623","article-title":"Molecular Mechanisms and Emerging Therapeutics for Osteoporosis","volume":"21","author":"Noh","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.17179\/excli2020-2591","article-title":"Osteoporosis: Pathophysiology and Therapeutic Options","volume":"19","author":"Foger-Samwald","year":"2020","journal-title":"EXCLI J"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.26402\/jpp.2020.3.01","article-title":"Pharmacological Agents and Natural Compounds: Available Treatments for Osteoporosis","volume":"71","author":"Martiniakova","year":"2020","journal-title":"J Physiol Pharmacol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctcp.2021.101419","article-title":"Efficacy of Chinese Patent Medicine for Primary Osteoporosis: A Network Meta-Analysis","volume":"44","author":"Zhao","year":"2021","journal-title":"Complement Ther Clin"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3717391","article-title":"Mechanisms of Zuogui Pill in Treating Osteoporosis: Perspective From Bone Marrow Mesenchymal Stem Cells","volume":"2018","author":"Yang","year":"2018","journal-title":"Evid-Based Compl Alt"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2174\/1381612822666151112150346","article-title":"Mechanism of Treatment of Kidney Deficiency and Osteoporosis is Similar by Traditional Chinese Medicine","volume":"22","author":"Wang","year":"2016","journal-title":"Curr Pharm Des"},{"key":"B9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jep.2016.05.025","article-title":"Traditional Chinese Medicine Formulas for the Treatment of Osteoporosis: Implication for Antiosteoporotic Drug Discovery","volume":"189","author":"Zhang","year":"2016","journal-title":"J Ethnopharmacol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.13863\/j.issn1001-4454.2021.01.046","article-title":"Research Progress on Modern Pharmacological Action of Polygonati Rhizoma","volume":"44","author":"Chen","year":"2021","journal-title":"J Chin Med Mater"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.19540\/j.cnki.cjcmm.20200522.601","article-title":"Research Progress on Processing History Evolution, Chemical Components and Pharmacological Effects of Polygonati Rhizoma","volume":"45","author":"Ren","year":"2020","journal-title":"China J Chin Mater Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/srep32261","article-title":"Polygonatum Sibiricum Polysaccharide Inhibits Osteoporosis by Promoting Osteoblast Formation and Blocking Osteoclastogenesis Through Wnt\/\u03b2-Catenin Signalling Pathway","volume":"6","author":"Du","year":"2016","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1006-5725.2017.08.013","article-title":"The Effect of Polygonatum Sibiricum Polysaccharide on the Expression of OPG and RANKL in the Rat Model of Ovariectomy-Induced Osteoporosis","volume":"33","author":"Yan","year":"2017","journal-title":"J Pract Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.2095-4344.0079","article-title":"Molecular Mechanism of Polygonatum Sibiricum Polysaccharide in the Prevention and Treatment of Postmenopausal Osteoporosis","volume":"22","author":"Zhang","year":"2018","journal-title":"Chin J Tissue Eng Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1875-5364(21)60001-8","article-title":"TCM Network Pharmacology: A New Trend Towards Combining Computational, Experimental and Clinical Approaches","volume":"19","author":"Wang","year":"2021","journal-title":"Chin J Nat Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/17435390.2020.1842537","article-title":"Interaction of Nanoparticles With Biological Macromolecules: A Review of Molecular Docking Studies","volume":"15","author":"Abdelsattar","year":"2021","journal-title":"Nanotoxicology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: A Database of Systems Pharmacology for Drug Discovery From Herbal Medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J Cheminformat"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1021\/ci000026+","article-title":"Drug-Like Index:\u2009 A New Approach To Measure Drug-Like Compounds and Their Diversity","volume":"40","author":"Xu","year":"2000","journal-title":"J Chem Inf Comput Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku293","article-title":"SwissTargetPrediction: A Web Server for Target Prediction of Bioactive Small Molecules","volume":"42","author":"Gfeller","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249455","article-title":"The Role of Epigenomics in Osteoporosis and Osteoporotic Vertebral Fracture","volume":"21","author":"Kim","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6345857","article-title":"Prevention and Treatment of Osteoporosis Using Chinese Medicinal Plants: Special Emphasis on Mechanisms of Immune Modulation","volume":"2018","author":"Zhao","year":"2018","journal-title":"J Immunol Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e130716","DOI":"10.1371\/journal.pone.0130716","article-title":"Development and Validation of an Osteoporosis Self-Assessment Tool for Taiwan (OSTAi) Postmenopausal Women-A Sub-Study of the Taiwan OsteoPorosis Survey (TOPS)","volume":"10","author":"Su","year":"2015","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.11847\/zgggws2017-33-12-31","article-title":"Anti-Tumor Effect of \u03b2-Sitosterol in H22 Tumor-Bearing Mice","volume":"33","author":"Lin","year":"2017","journal-title":"Chin J Public Health"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2020.1818883","article-title":"\u03b2-Sitosterol-Loaded Solid Lipid Nanoparticles Ameliorate Complete Freund\u2019s Adjuvant-Induced Arthritis in Rats: Involvement of NF-\u041ab and HO-1\/Nrf-2 Pathway","volume":"27","author":"Zhang","year":"2020","journal-title":"Drug Deliv"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28721","article-title":"HIF-1\u03b1 Facilitates Osteocyte-Mediated Osteoclastogenesis by Activating JAK2\/STAT3 Pathway","volume":"234","author":"Zhu","year":"2019","journal-title":"Vitro J Cell Physiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31581","article-title":": The Hypoxia-Inducible Factor \u03b1 Pathway Couples Angiogenesis to Osteogenesis During Skeletal Development","volume":"117","author":"Wang","year":"2007","journal-title":"J Clin Invest"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbre.2016.07.008","article-title":"Role of HIF-1\u03b1 Signaling Pathway in Osteoarthritis: A Systematic Review","volume":"57","author":"Fern\u00e1ndez-Torres","year":"2017","journal-title":"Rev Bras Reumatol (English Ed)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/bbb\/zbaa010","article-title":"Morroniside Promotes the Osteogenesis by Activating PI3K\/Akt\/mTOR Signaling","volume":"85","author":"Liu","year":"2021","journal-title":"Biosci Biotechnol Biochem"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-018-1574-9","article-title":"Orthosilicic Acid Accelerates Bone Formation in Human Osteoblast-Like Cells Through the PI3K\u2013Akt\u2013mTOR Pathway","volume":"190","author":"Zhou","year":"2019","journal-title":"Biol Trace Elem Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbiomolbio.2016.05.008","article-title":"Disturbed MEK\/ERK Signaling Increases Osteoclast Activity via the Hedgehog-Gli Pathway in Postmenopausal Osteoporosis","volume":"122","author":"Li","year":"2016","journal-title":"Prog Biophys Mol Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2019.105375","article-title":"Functions of Estrogen and Estrogen Receptor Signaling on Skeletal Muscle","volume":"191","author":"Ikeda","year":"2019","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.815891\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T06:28:35Z","timestamp":1641364115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.815891\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,5]]},"references-count":31,"alternative-id":["10.3389\/fendo.2021.815891"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.815891","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,5]]},"article-number":"815891"}}